Len Van Lin
29 May 2025
Viral Clearance Strategies for Biopharmaceuticals and Cell & Gene Therapies
7-hour
Risk and impact of viral contamination in biopharmaceutical manufacturing, Regulatory landscape, Examine the requirements of specific products, Risk prevention and Viral clearance studies
Mylène Talabardon and Hervé Broly

Distributed by:

Issued to

Len Van Lin

Want to report a typo or a mistake?

Credential Verification

Issue date: May 29, 2025

ID: 4e56ea42-891e-4997-864a-902d044e3202

Educo Life Sciences is a learning and development specialist that provides technical training solutions to the pharmaceutical, biotechnology, cell and gene, and medical device industries. ,

Type

Course

Level

Professional

Format

Online

Duration

7 hours

Price

Paid

Description

The holder of this certificate has attended the course "Viral Clearance Strategies for Biopharmaceuticals and Cell & Gene Therapies".

This short live online training course will enable you to understand the risk and impact of viral contamination in biopharmaceutical manufacturing. You will review the viral contamination and clearance guidance such as ICH Q5A to ensure your products comply. As well as risk prevention, you will examine in-depth viral clearance strategies and studies. Once completed, you will know what studies are required and when during CMC development to demonstrate safe viral inactivation and removal.

Skills

Biopharmaceutical Manufacturing

Biopharmaceuticals

viral clearance

CMC

Earning Criteria

Participation

Attended the live online or in-person course held by Educo Life Sciences.

Watching

Or watched the recorded materials for the course held by Educo.